196 | Chapter 9 16. Taha K, Bourfiss M, te Riele ASJM, et al. A head-to-head comparison of speckle tracking echocardiography and feature tracking cardiovascular magnetic resonance imaging in right ventricular deformation. Eur Heart J Cardiovasc Imaging. 2021;22(8):950–8. 17. Kloosterman M, Boonstra MJ, Roudijk RW, et al. Body surface potential mapping detects early disease onset in Plakophilin-2 pathogenic variant carriers. Europace. 2023;25(7):euad197. 18. Tsui H, van Kampen SJ, Han SJ, et al. Desmosomal protein degradation as an underlying cause of arrhythmogenic cardiomyopathy. Sci Transl Med. 2023;15(688):eadd4248. 19. Schut B. Pump: A Natural History of the Heart. New York: Algonquin books; 2021. 20. Gülan U, Saguner AM, Akdis D, et al. Hemodynamic Changes in the Right Ventricle Induced by Variations of Cardiac Output: A Possible Mechanism for Arrhythmia Occurrence in the Outflow Tract. Sci Rep. 2019;9(1):100. 21. Te Riele ASJM, James CA, Philips B, et al. Mutation-positive arrhythmogenic right ventricular dysplasia/ cardiomyopathy: The triangle of dysplasia displaced. J Cardiovasc Electrophysiol. 2013;24(12):1311–20. 22. Mast TP, Teske AJ, Vd Heijden JF, et al. Left Ventricular Involvement in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Assessed by Echocardiography Predicts Adverse Clinical Outcome. J Am Soc Echocardiogr. 2015;28(9):1103-1113. 23. Dejgaard LA, Skjølsvik ET, Lie ØH, et al. The Mitral Annulus Disjunction Arrhythmic Syndrome. J Am Coll Cardiol. 2018;72(14):1600–9. 24. Essayagh B, Sabbag A, El-Am E, Cavalcante JL, Michelena HI, Enriquez-Sarano M. Arrhythmic mitral valve prolapse and mitral annular disjunction: pathophysiology, risk stratification, and management. Eur Heart J. 2023;44(33):3121–35. 25. James CA, Bhonsale A, Tichnell C, et al. Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. J Am Coll Cardiol. 2013;62(14):1290–7. 26. Lie ØH, Dejgaard LA, Saberniak J, et al. Harmful Effects of Exercise Intensity and Exercise Duration in Patients With Arrhythmogenic Cardiomyopathy. JACC Clin Electrophysiol. 2018;4(6):744–53. 27. Bosman LP, Wang W, Lie ØH, et al. Integrating Exercise Into Personalized Ventricular Arrhythmia Risk Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy. Circ Arrhythm Electrophysiol. 2022;15(2):e010221. 28. Cruz FM, Sanz-Rosa D, Roche-Molina M, et al. Exercise Triggers ARVC Phenotype in Mice Expressing a Disease-Causing Mutated Version of Human Plakophilin-2. J Am Coll Cardiol. 2015;65(14):1438–50. 29. van Opbergen CJM, Bagwan N, Maurya SR, et al. Exercise Causes Arrhythmogenic Remodeling of Intracellular Calcium Dynamics in Plakophilin-2–Deficient Hearts. Circulation. 2022;145(19):1480–96. 30. La Gerche A, Heidbuchel H, Burns A, et al. Disproportionate Exercise Load and Remodeling of the Athlete’s Right Ventricle. Med Sci Sports Exerc. 2011 Jun;43(6):974–81. 31. La Gerche A, Claessen G, Dymarkowski S, et al. Exercise-induced right ventricular dysfunction is associated with ventricular arrhythmias in endurance athletes. Eur Heart J. 2015;36(30):1998–2010. 32. Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43(40):3997–4126.
RkJQdWJsaXNoZXIy MTk4NDMw